ACON Aclarion, Inc.
Healthcare$3.16-1.56%ClosedMarket Cap: $1.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.35
P/S
21.98
EV/EBITDA
2.18
DCF Value
$20.52
FCF Yield
-429.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-58.9%
Operating Margin
-10975.1%
Net Margin
-10336.1%
ROE
-54.4%
ROA
-39.0%
ROIC
-43.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $21.1K | -270.4% | $-3.0M | $-2.9M | $— | — |
| Q4 null | $18.5K | 9.7% | $-2.0M | $-1.9M | $— | — |
| FY null | $75.7K | -291.3% | $-7.1M | $-7.2M | $— | — |
| Q3 null | $18.9K | 23.2% | $-1.8M | $-1.7M | $— | — |
| Q2 null | $19.3K | 26.6% | $-1.7M | $-1.6M | $— | — |
| Q1 null | $19.0K | -23.6% | $-1.5M | $-2.0M | $— | — |
| Q4 null | $10.2K | -100.9% | $-1.8M | $-2.0M | $— | — |
| FY null | $45.7K | -183.8% | $-5.5M | $-7.0M | $— | — |
| Q3 null | $14.4K | -48.1% | $-1.3M | $-1.4M | $— | — |
| Q2 null | $11.0K | -112.3% | $-1.1M | $-1.2M | $— | — |
| Q1 null | $10.1K | -92.6% | $-1.3M | $-2.4M | $— | — |
| Q4 2023 | $13.8K | -40.7% | $-1.1M | $-1.3M | $-13,865.00 | — |